✦ LIBER ✦

Phase II Study of Oral Etoposide and Intravenous Irinotecan for Patients with Platinum-resistant and Taxane-pretreated Ovarian Cancer: Japan Clinical Oncology Group Study 0503

✍ Scribed by Matsumoto, K.; Katsumata, N.; Saito, I.; Shibata, T.; Konishi, I.; Fukuda, H.; Kamura, T.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

934 POSTER Phase II study of irinotecan

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Phase II study of bevacizumab with lipos

✍ Verschraegen, C. F.; Czok, S.; Muller, C. Y.; Boyd, L.; Lee, S. J.; Rutledge, T. 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 144 KB

Second-Line Treatment with Intravenous G

✍ Bruzzone, M.; Centurioni, M.G.; Giglione, P.; Gualco, M.; Merlo, D.F.; Miglietta 📂 Article 📅 2011 🏛 S. Karger AG 🌐 English ⚖ 469 KB

A phase II study of biweekly mitomycin C

✍ Tetsuya Hamaguchi; Kuniaki Shirao; Atsushi Ohtsu; Ichinosuke Hyodo; Yasuaki Arai 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 341 KB

Phase I/II trial of cisplatin (CDDP), et

✍ Makino, M; Tsukada, H; Yokoyama, A; Kurita, Y; Isobe, H; Watanabe, K; Saijo, N 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 129 KB

A phase II study of intravenous exatecan

✍ Claire F. Verschraegen; Andrzej P. Kudelka; Wei Hu; Monique Vincent; John J. Kay 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 736 KB